Investing
Prismo Metals Announces Private Placement and Ripsey Gold Project Overlimit Silver Assay Results
(TheNewswire) NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia...
Read more
Bold Ventures Highlights Burchell Gold Copper Project News
Bold Ventures Inc. (TSXV: BOL,OTC:BVLDF) (the ‘Company’ or ‘Bold’) is pleased to highlight news from the area of its Burchell...
Read more
Eric Sprott Announces Acquisition of Common Shares of Silverco Mining Ltd.
Eric Sprott announces that, on October 17, 2025, 2176423 Ontario Ltd., a corporation beneficially owned by him, acquired 4,637,960 common...
Read more
Titan on Track for New York Graphite Production as US Pushes for Domestic Supply Chain
Titan Mining (TSX:TI,OTCQB:TIMCF) is on track to start producing natural graphite concentrate at its Empire State operation in Gouverneur, New...
Read more
FALCO ANNOUNCES CLOSING OF BOUGHT DEAL PRIVATE PLACEMENT
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TSX.V – FPC Falco Resources...
Read more
Vince Lanci: Silver’s London Liquidity Crisis — What’s Happening, What’s Next
Vince Lanci of Echobay Partners explains what’s driving silver’s record-setting price run. According to Lanci, who is also a professor...
Read more
CSE Bulletin: MOC Eligibility Update
The following CSE-Listed symbol will become MOC Eligible as detailed below. Symbol Company Name Effective Date AIML AI/ML Innovations Inc....
Read more
US Cancels US$500 Million Cobalt Tender in Setback for Critical Minerals Strategy
The US Department of Defense has canceled its long-awaited plan to buy up to US$500 million worth of cobalt, a...
Read more
Top 5 Canadian Mining Stocks This Week: JZR Gold Jumps 113 Percent
The Government of Ontario started taking applications for resource development projects under its “One Project, One Process” framework on Friday...
Read more
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned...
Read more
